Acquired haemophilia in cancer: A systematic and critical literature review.
Mariasanta NapolitanoS SiragusaS MancusoC M KesslerPublished in: Haemophilia : the official journal of the World Federation of Hemophilia (2017)
CR was best achieved when successful and complete elimination of autoantibodies occurred contemporaneously with the successful treatment of the underlying malignancy. In some cases, recurrent autoantibodies were harbingers of relapsed cancer. Type of cancer, inhibitor titer, treatments administered for bleeding control and inhibitor eradication did not significantly affect clinical outcome of analyzed cases.